CLINICAL TRIAL AGREEMENT DOHODA O KLINICKÉM HODNOCENÍClinical Trial Agreement • July 8th, 2022
Contract Type FiledJuly 8th, 2022Sponsor ADC Therapeutics SA CRO Pharmaceutical Research Associates CZ, s.r.o. Institution Fakultní nemocnice Brno Principal Investigator xxxxxxxxxxxx Protocol Number ADCT-402-105 Study Drug (ADCT-402) Study Title A Phase 1b Open-Label Study to Evaluate the Safety and Anti- cancer Activity of Loncastuximab Tesirine in Combination with Other Anti- cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS 7)